Global Leishmaniasis Treatment Market Research Report 2023

Report ID: 1879655 | Published Date: Jan 2025 | No. of Page: 86 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Leishmaniasis Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Meglumine Antimoniate
        1.2.3 Pentamidine
        1.2.4 Hydroxyl Amidine Stilbene
        1.2.5 Amphotericin B
    1.3 Market by Application
        1.3.1 Global Leishmaniasis Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Visceral Leishmaniasis
        1.3.3 Cutaneous Leishmaniasis
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Leishmaniasis Treatment Market Perspective (2017-2028)
    2.2 Leishmaniasis Treatment Growth Trends by Region
        2.2.1 Leishmaniasis Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Leishmaniasis Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Leishmaniasis Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Leishmaniasis Treatment Market Dynamics
        2.3.1 Leishmaniasis Treatment Industry Trends
        2.3.2 Leishmaniasis Treatment Market Drivers
        2.3.3 Leishmaniasis Treatment Market Challenges
        2.3.4 Leishmaniasis Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Leishmaniasis Treatment Players by Revenue
        3.1.1 Global Top Leishmaniasis Treatment Players by Revenue (2017-2022)
        3.1.2 Global Leishmaniasis Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Leishmaniasis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Leishmaniasis Treatment Revenue
    3.4 Global Leishmaniasis Treatment Market Concentration Ratio
        3.4.1 Global Leishmaniasis Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Leishmaniasis Treatment Revenue in 2021
    3.5 Leishmaniasis Treatment Key Players Head office and Area Served
    3.6 Key Players Leishmaniasis Treatment Product Solution and Service
    3.7 Date of Enter into Leishmaniasis Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Leishmaniasis Treatment Breakdown Data by Type
    4.1 Global Leishmaniasis Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Leishmaniasis Treatment Forecasted Market Size by Type (2023-2028)
5 Leishmaniasis Treatment Breakdown Data by Application
    5.1 Global Leishmaniasis Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Leishmaniasis Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Leishmaniasis Treatment Market Size (2017-2028)
    6.2 North America Leishmaniasis Treatment Market Size by Country (2017-2022)
    6.3 North America Leishmaniasis Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Leishmaniasis Treatment Market Size (2017-2028)
    7.2 Europe Leishmaniasis Treatment Market Size by Country (2017-2022)
    7.3 Europe Leishmaniasis Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Leishmaniasis Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Leishmaniasis Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Leishmaniasis Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Leishmaniasis Treatment Market Size (2017-2028)
    9.2 Latin America Leishmaniasis Treatment Market Size by Country (2017-2022)
    9.3 Latin America Leishmaniasis Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Leishmaniasis Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Leishmaniasis Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Leishmaniasis Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Detail
        11.1.2 Merck Business Overview
        11.1.3 Merck Leishmaniasis Treatment Introduction
        11.1.4 Merck Revenue in Leishmaniasis Treatment Business (2017-2022)
        11.1.5 Merck Recent Development
    11.2 iCo Therapeutics
        11.2.1 iCo Therapeutics Company Detail
        11.2.2 iCo Therapeutics Business Overview
        11.2.3 iCo Therapeutics Leishmaniasis Treatment Introduction
        11.2.4 iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2017-2022)
        11.2.5 iCo Therapeutics Recent Development
    11.3 AEterna Zentaris
        11.3.1 AEterna Zentaris Company Detail
        11.3.2 AEterna Zentaris Business Overview
        11.3.3 AEterna Zentaris Leishmaniasis Treatment Introduction
        11.3.4 AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2017-2022)
        11.3.5 AEterna Zentaris Recent Development
    11.4 AEterna Zentaris AG
        11.4.1 AEterna Zentaris AG Company Detail
        11.4.2 AEterna Zentaris AG Business Overview
        11.4.3 AEterna Zentaris AG Leishmaniasis Treatment Introduction
        11.4.4 AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2017-2022)
        11.4.5 AEterna Zentaris AG Recent Development
    11.5 Eurofins Advinus
        11.5.1 Eurofins Advinus Company Detail
        11.5.2 Eurofins Advinus Business Overview
        11.5.3 Eurofins Advinus Leishmaniasis Treatment Introduction
        11.5.4 Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2017-2022)
        11.5.5 Eurofins Advinus Recent Development
    11.6 Pieris Pharmaceuticals
        11.6.1 Pieris Pharmaceuticals Company Detail
        11.6.2 Pieris Pharmaceuticals Business Overview
        11.6.3 Pieris Pharmaceuticals Leishmaniasis Treatment Introduction
        11.6.4 Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2017-2022)
        11.6.5 Pieris Pharmaceuticals Recent Development
    11.7 Dafra Pharma
        11.7.1 Dafra Pharma Company Detail
        11.7.2 Dafra Pharma Business Overview
        11.7.3 Dafra Pharma Leishmaniasis Treatment Introduction
        11.7.4 Dafra Pharma Revenue in Leishmaniasis Treatment Business (2017-2022)
        11.7.5 Dafra Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Leishmaniasis Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Meglumine Antimoniate
    Table 3. Key Players of Pentamidine
    Table 4. Key Players of Hydroxyl Amidine Stilbene
    Table 5. Key Players of Amphotericin B
    Table 6. Global Leishmaniasis Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Leishmaniasis Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Leishmaniasis Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Leishmaniasis Treatment Market Share by Region (2017-2022)
    Table 10. Global Leishmaniasis Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Leishmaniasis Treatment Market Share by Region (2023-2028)
    Table 12. Leishmaniasis Treatment Market Trends
    Table 13. Leishmaniasis Treatment Market Drivers
    Table 14. Leishmaniasis Treatment Market Challenges
    Table 15. Leishmaniasis Treatment Market Restraints
    Table 16. Global Leishmaniasis Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Leishmaniasis Treatment Market Share by Players (2017-2022)
    Table 18. Global Top Leishmaniasis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leishmaniasis Treatment as of 2021)
    Table 19. Ranking of Global Top Leishmaniasis Treatment Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Leishmaniasis Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Leishmaniasis Treatment Product Solution and Service
    Table 23. Date of Enter into Leishmaniasis Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Leishmaniasis Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Leishmaniasis Treatment Revenue Market Share by Type (2017-2022)
    Table 27. Global Leishmaniasis Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Leishmaniasis Treatment Revenue Market Share by Type (2023-2028)
    Table 29. Global Leishmaniasis Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Leishmaniasis Treatment Revenue Market Share by Application (2017-2022)
    Table 31. Global Leishmaniasis Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Leishmaniasis Treatment Revenue Market Share by Application (2023-2028)
    Table 33. North America Leishmaniasis Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Leishmaniasis Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Leishmaniasis Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Leishmaniasis Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Leishmaniasis Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Leishmaniasis Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Leishmaniasis Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Leishmaniasis Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Leishmaniasis Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Leishmaniasis Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Merck Company Detail
    Table 44. Merck Business Overview
    Table 45. Merck Leishmaniasis Treatment Product
    Table 46. Merck Revenue in Leishmaniasis Treatment Business (2017-2022) & (US$ Million)
    Table 47. Merck Recent Development
    Table 48. iCo Therapeutics Company Detail
    Table 49. iCo Therapeutics Business Overview
    Table 50. iCo Therapeutics Leishmaniasis Treatment Product
    Table 51. iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2017-2022) & (US$ Million)
    Table 52. iCo Therapeutics Recent Development
    Table 53. AEterna Zentaris Company Detail
    Table 54. AEterna Zentaris Business Overview
    Table 55. AEterna Zentaris Leishmaniasis Treatment Product
    Table 56. AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2017-2022) & (US$ Million)
    Table 57. AEterna Zentaris Recent Development
    Table 58. AEterna Zentaris AG Company Detail
    Table 59. AEterna Zentaris AG Business Overview
    Table 60. AEterna Zentaris AG Leishmaniasis Treatment Product
    Table 61. AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2017-2022) & (US$ Million)
    Table 62. AEterna Zentaris AG Recent Development
    Table 63. Eurofins Advinus Company Detail
    Table 64. Eurofins Advinus Business Overview
    Table 65. Eurofins Advinus Leishmaniasis Treatment Product
    Table 66. Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2017-2022) & (US$ Million)
    Table 67. Eurofins Advinus Recent Development
    Table 68. Pieris Pharmaceuticals Company Detail
    Table 69. Pieris Pharmaceuticals Business Overview
    Table 70. Pieris Pharmaceuticals Leishmaniasis Treatment Product
    Table 71. Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2017-2022) & (US$ Million)
    Table 72. Pieris Pharmaceuticals Recent Development
    Table 73. Dafra Pharma Company Detail
    Table 74. Dafra Pharma Business Overview
    Table 75. Dafra Pharma Leishmaniasis Treatment Product
    Table 76. Dafra Pharma Revenue in Leishmaniasis Treatment Business (2017-2022) & (US$ Million)
    Table 77. Dafra Pharma Recent Development
    Table 78. Research Programs/Design for This Report
    Table 79. Key Data Information from Secondary Sources
    Table 80. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Leishmaniasis Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Meglumine Antimoniate Features
    Figure 3. Pentamidine Features
    Figure 4. Hydroxyl Amidine Stilbene Features
    Figure 5. Amphotericin B Features
    Figure 6. Global Leishmaniasis Treatment Market Share by Application in 2021 & 2028
    Figure 7. Visceral Leishmaniasis Case Studies
    Figure 8. Cutaneous Leishmaniasis Case Studies
    Figure 9. Leishmaniasis Treatment Report Years Considered
    Figure 10. Global Leishmaniasis Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Leishmaniasis Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Leishmaniasis Treatment Market Share by Region: 2021 VS 2028
    Figure 13. Global Leishmaniasis Treatment Market Share by Players in 2021
    Figure 14. Global Top Leishmaniasis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leishmaniasis Treatment as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Leishmaniasis Treatment Revenue in 2021
    Figure 16. North America Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Leishmaniasis Treatment Market Share by Country (2017-2028)
    Figure 18. United States Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Leishmaniasis Treatment Market Share by Country (2017-2028)
    Figure 22. Germany Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Leishmaniasis Treatment Market Share by Region (2017-2028)
    Figure 30. China Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Leishmaniasis Treatment Market Share by Country (2017-2028)
    Figure 38. Mexico Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Leishmaniasis Treatment Market Share by Country (2017-2028)
    Figure 42. Turkey Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Merck Revenue Growth Rate in Leishmaniasis Treatment Business (2017-2022)
    Figure 45. iCo Therapeutics Revenue Growth Rate in Leishmaniasis Treatment Business (2017-2022)
    Figure 46. AEterna Zentaris Revenue Growth Rate in Leishmaniasis Treatment Business (2017-2022)
    Figure 47. AEterna Zentaris AG Revenue Growth Rate in Leishmaniasis Treatment Business (2017-2022)
    Figure 48. Eurofins Advinus Revenue Growth Rate in Leishmaniasis Treatment Business (2017-2022)
    Figure 49. Pieris Pharmaceuticals Revenue Growth Rate in Leishmaniasis Treatment Business (2017-2022)
    Figure 50. Dafra Pharma Revenue Growth Rate in Leishmaniasis Treatment Business (2017-2022)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
iCo Therapeutics
AEterna Zentaris
AEterna Zentaris AG
Eurofins Advinus
Pieris Pharmaceuticals
Dafra Pharma
Frequently Asked Questions
Leishmaniasis Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Leishmaniasis Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Leishmaniasis Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Composite Roll

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More